Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 28th Annual Meeting of the American Academy of Pain Medicine
Pain Treatment: Focus on Abuse Potential
Palm Springs, California / February 22-26, 2012
Palm Springs - The potential for abuse is one of the most important stumbling blocks for appropriate use of opioids. Even though there is very little risk of dependence when opioids are used in a structured pain management protocol,...
PRIORITY PRESS - 28th Annual Meeting of the American Academy of Pain Medicine
Expanded Options for Effective Acute Pain Control
Palm Springs, California / February 22-26, 2012
Palm Springs - Effective relief of acute pain is being increasingly recognized as an important defense against the onset of chronic pain. While the traditional focus in patients presenting with an injury and acute pain has been to treat the...
PRIORITY PRESS - The XIX World Congress on Parkinson’s Disease and Related Disorders
Recognizing and Treating the Signs and Symptoms of Parkinson’s Disease: Update
Shanghai, China / December 11-14, 2011
Shanghai - Here at the World Congress on Parkinson’s Disease and Related Disorders, experts in the field discussed the progress being made in identifying the earliest signs and symptoms of Parkinson’s disease before the onset of...
MEDICAL FRONTIERS - 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS)
Evolving Landscape in the Treatment of Multiple Sclerosis
Amsterdam, The Netherlands / October 19-22, 2011
Amsterdam - The development of disease-modifying therapies in multiple sclerosis (MS) has been rapidly evolving over the past few years with approvals in the 1990s of the first-generation drugs, beta-interferons and glatiramer acetate, to...
MEDICAL FRONTIERS - 5th Joint Triennial Congress European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS 2011)
The Promise of Oral MS Therapies Weighed Against the Defined Benefits of Established Agents
Amsterdam, The Netherlands / October 19-22, 2011
Amsterdam - The first ECTRIMS meeting to convene since an oral disease-modifying therapy (DMT) for multiple sclerosis (MS) was approved in Canada provided a forum to consider both potential applications and potential concerns of expanding...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS 2011)
Expanding Therapeutic Options in Multiple Sclerosis Treatment: Current Perspectives
Amsterdam, The Netherlands / October 19-22, 2011
Guest Editor: J. Marc Girard, MD, FRCPCMultiple Sclerosis ClinicNotre-Dame HospitalAssistant Professor of MedicineUniversité de MontréalMontréal, Quebec To see an interview with Dr. Girard, select the "video"...
PRIORITY PRESS - 61st Annual Refresher Course for Family Physicians
Addressing Cardiovascular Health and Back Pain
McGill University, Montreal, Quebec / November 28-December 1, 2010
Which Lifestyle Changes Are Effective? Lifestyle measures can promote overall health, help effect disease prevention and modestly extend life and may be more effective than increasing doses of antihypertensive and/or lipid-lowering...
MEDICAL FRONTIERS - 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
The Expanding Treatment Options for Multiple Sclerosis
Gothenburg, Sweden / October 13-16, 2010
Gothenburg - With several new compounds reaching the end of development, there is an ever-widening choice of therapy for patients with relapsing-remitting multiple sclerosis (RRMS). The choice is not obvious, however, when planning the...
PRIORITY PRESS - 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Emerging Oral Agents for Multiple Sclerosis
Gothenburg, Sweden / October 13-16, 2010
Gothenburg - Conventional therapies for relapsing-remitting multiple sclerosis (RRMS) require parenteral administration and are known for their relative effectiveness. However, new emerging oral agents also appear effective in reducing the...